Evaxion Biotech's market cap is currently ―. The company's EPS TTM is $-8.238; its P/E ratio is -0.52; Evaxion Biotech is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-1.09. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	-	-	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	-	-	$ -5.38M	$ -4.72M	$ -5.88M
EBITDA	-	-	$ -5.38M	$ -4.72M	$ -5.88M
Net Income Common Stockholders	-	-	$ -5.74M	$ -4.77M	$ -5.79M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 5.58M	$ 13.18M	$ 17.85M	$ 25.25M	$ 31.41M
Total Assets	$ 12.89M	$ 22.02M	$ 27.45M	$ 34.00M	$ 41.08M
Total Debt	$ 10.87M	$ 10.26M	$ 0.00	$ 9.72M	$ 10.29M
Net Debt	$ 5.29M	$ -2.93M	$ -17.85M	$ -15.54M	$ -21.12M
Total Liabilities	$ 17.62M	$ 13.72M	$ 13.90M	$ 13.85M	$ 14.69M
Stockholders Equity	$ -4.73M	$ -72.66M	$ -65.76M	$ 20.15M	$ 26.39M
Cash Flow	-
Free Cash Flow	-	-	-	$ -5.27M	$ -8.37M
Operating Cash Flow	-	-	-	$ -5.19M	$ -8.19M
Investing Cash Flow	-	-	-	$ -77.00K	$ -159.00K
Financing Cash Flow	-	-	-	$ -300.00K	$ 7.74M

Currency in USD

Evaxion Biotech Earnings and Revenue History

Income Statement >

Evaxion Biotech Debt to Assets

Balance Sheet >

Evaxion Biotech Cash Flow

Cash Flow >

Evaxion Biotech Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing